CIK 0001034842
- Accelerated filer
RIGEL PHARMACEUTICALS INC
Sign in to watch- Ticker
- RIGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943248524
- Phone
- +1 650-624-1100
- Business address
- 611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- RIGEL PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-01-26 | Grossbard Elliott B EVP, CMO | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2016-01-26 | PAYAN DONALD G EVP, Pres. Discovery&Research | Grant or award · Stock Option (Right to Buy) | +165,000 | 165,000 | ||
| 2016-01-26 | RODRIGUEZ RAUL R CEO, President | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2015-06-29 | Katkin Keith Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2015-06-10 | PAYAN DONALD G EVP, Pres. Discovery&Research | Exercise or conversion | +41,666 | $2.14 | $89K | 100,000 |
| 2015-06-10 | PAYAN DONALD G EVP, Pres. Discovery&Research | Sale | −41,666 | $3.68 | $153K | 58,334 |
| 2015-06-10 | PAYAN DONALD G EVP, Pres. Discovery&Research | Exercise or conversion · Stock Option (Right to Buy) | −41,666 | 158,334 | ||
| 2015-05-13 | Goodwin Bradford S Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2015-05-13 | MOOS WALTER H Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2015-05-13 | RINGROSE PETER S Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2015-05-13 | SHERWIN STEPHEN A Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2015-05-13 | LYONS GARY A Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2015-04-01 | PAYAN DONALD G EVP, Pres. Discovery&Research | Sale | −10,000 | $3.75 | $38K | 58,334 |
| 2015-01-26 | Maynard Ryan D EVP & CFO | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2015-01-26 | VANCE DOLLY EVP Corp. Affairs, G.C., Sect. | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2015-01-26 | Grossbard Elliott B EVP, CMO | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2015-01-26 | PAYAN DONALD G EVP, Pres. Discovery&Research | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2015-01-26 | RODRIGUEZ RAUL R CEO, President | Grant or award · Stock Option (Right to Buy) | +450,000 | 450,000 | ||
| 2014-12-18 | VANCE DOLLY EVP Corp. Affairs, G.C., Sect. | Sale | −1,000 | $2.22 | $2K | 575 |
| 2014-12-18 | VANCE DOLLY EVP Corp. Affairs, G.C., Sect. | Sale | +1,000 | $2.22 | $2K | 575 |
Page 20 of 22 · 423 trades